Moutainside, NJ), and examined for S. aureus or VRE. S. aureus was confirmed by positive StaphAurex (Remel, Lenexa, KS), tube coagulase, Vogues-Proskauer, mannitol, and trehalose reactions; Enterococcus isolates were identified with the Vitek2 system (bioMérieux, St. Louis, MO). Antimicrobial susceptibility testing was performed by broth microdilution with panels prepared in house (12) .
MRSA was isolated from nasal and rectal swabs, and vancomycin-resistant Enterococcus faecalis was isolated from the rectal swab; no VRSA bacteria were detected at either site. The MRSA isolates from both sites were characterized as PFGE type Archaic/ Iberian and spa type t064 (CC8) and thus could not be implicated as direct progenitors of VRSA isolate 13. Although the rectal and nasal MRSA isolates were closely related, they displayed different antimicrobial susceptibility patterns, and only one (rectal) isolate carried PCR markers indicative of a pSK41-like plasmid (Tables 1  and 2 ). The vancomycin-resistant E. faecalis isolate was found to contain vanA, as well as repR, a marker of Inc18-type plasmids (13) ( Table 2 ). The VRSA isolate was not PCR positive for pSK41 markers but, like the putative VRE donor, was positive for the Inc18-like plasmid marker repR.
Persons deemed to be at increased risk for VRSA acquisition included the patient's LTCF roommate and infectious disease physician, the patient's primary care provider, and the podiatrist who cultured and treated the patient's VRSA-positive wound. Because of the 2-month interval between LTCF discharge and VRSA culture, the patient's roommate was no longer a resident of the LTCF and could not be located, but review of the roommate's medical record during the 2 weeks following the discharge of the case patient revealed that urine, respiratory, and blood cultures during this time were negative. Cultures were not collected from the primary care provider or infectious disease physician, since neither had any contact with the patient between April and June 2012. The podiatrist stated that he was the only person in his office to perform wound care, and he refused to be cultured for surveillance.
The first U.S. case of vanA-mediated vancomycin resistance in S. aureus was recognized in 2002 in an isolate from a foot wound of a diabetic patient who had received long-term vancomycin therapy. Since that time, VRSA has been viewed as a potential clinical and public health threat, although the widespread emergence of these organisms has not been realized (Fig. 1) . None of the U.S. VRSA isolates has been transmitted beyond the patient from whom it was cultured, and none has definitively contributed to patient morbidity or mortality, despite the fact that most VRSA strains have arisen from successful MRSA parent lineages that are both widespread and pathogenic.
Each of the 13 U.S. VRSA isolates has arisen from independent transfer of the vanA gene cluster on a conjugative element from a VRE donor to a MRSA recipient (4, 8, 14) . Despite the fact that VRSA isolate 13 represents the third VRSA isolate recovered from Delaware during a 3-year period, both microbiologic and epidemiologic data ( Fig. 1 and Table 2 ; CDC unpublished data) point to independent genetic events rather than transfer of VRSA between patients. VRSA appears to arise in vivo in settings of polymicrobial infections where VRE and MRSA are both present. For several VRSA cases, presumed donor VRE and/or recipient MRSA strains were recovered and characterized. Eight of 10 VRE strains associated with VRSA cases carried the vanA operon on an Inc18-like plasmid (Table 2 ) (4) and could transfer vanA to a naive MRSA donor in vitro (15) . Although Enterococcus faecium is the most common species of VRE in the United States, most VRSA isolates have been associated with species other than E. faecium. Among the 10 VRSA cases in which an associated VRE strain was recovered, only two E. faecium strains were identified, and neither contained an Inc18-like plasmid (Table 2 ) (4). Inc18-like plasmids are uncommon among VRE strains in the United States, but they appear over five times more commonly in Michigan than in other states (13) . This may, in part, explain why eight (62%) U.S. VRSA cases have occurred in Michigan.
The recipient strain also plays a significant role in the generation of VRSA. In VRSA isolate 1, a Tn1546 transposon carrying the vanA operon was found inserted into a pSK41-like S. aureus conjugative plasmid (14) . In addition to being important vectors for antibiotic resistance genes (16, 17) , pSK41-like plasmids also appear to be important as facilitators of DNA transfer between Enterococcus donors and S. aureus recipients (15) . PCR markers of pSK41-like plasmids were associated with seven VRSA cases; four of seven MRSA isolates from VRSA case patients carried pSK41 markers, as did three of six VRSA isolates that lacked an associated MRSA strain (Table 2) . Thus, the prevalence of pSK41-like plasmids among different MRSA strains may impact the lineages in which VRSA arises. A recent study of outpatients with lower-extremity wounds found that although pSK41-like plasmids had a low prevalence (5.4%), they were present among methicillin-susceptible S. aureus and MRSA strains from health care and community-associated lineages (18) . That recovery of MRSA bacteria in association with VRSA isolate 13 that were not immediate progenitors to the VRSA is unusual. The presence of a pSK41-like plasmid in the rectal Archaic/Iberian isolate suggests that it may have been a cocolonizer that facilitated conjugation between VRE and the VRSA progenitor, USA1100 MRSA.
Prior to this case, all U.S. VRSA isolates had been in the S. aureus CC5 lineage. This may reflect the fact that MRSA and VRE coinfection (or cocolonization) is more likely in patients with health care exposures, among whom health care-associated MRSA strains are common. CC5 is the dominant S. aureus lineage among health care-associated MRSA strains, encompassing both the USA100 and USA800 PFGE types, as well as related unnamed strains. The case patient described here had significant health care exposure, and this infection is clearly health care associated, but the USA1100/t019/CC30 lineage to which VRSA isolate 13 belongs is usually associated with community-acquired infections (9, 19) . Both of the MRSA strains recovered here belong to the Archaic-Iberian/t064/CC8 lineage, a strain most common in Europe and recently linked to nosocomial infections in horses (20) but relatively uncommon in the United States (6) . Neither USA1100 nor the Archaic-Iberian lineage has previously been associated with VRSA. Although the VRSA isolate 13 case patient had been an outpatient for approximately 2 months prior to the culture of VRSA, vancomycin exposure occurred primarily during his residence in an LTCF. However, the finding of MRSA containing pSK41-like plasmids among community-associated lineages (USA 300) in outpatients with chronic wounds (18) supports the possibility that vanA could transfer to community-associated MRSA strains in outpatient settings. VRSA isolates have been infrequently reported from other countries, including India, Iran, Pakistan (21) , and most recently Portugal (22) , and the possibility of significant dissemination of VRSA is an important concern for health care providers and for public health. The potential emergence of vanA-mediated vancomycin resistance among MRSA strains that are well adapted to transmission in community settings (e.g., USA300) could potentially increase the health risks associated with VRSA. Although it is not completely clear where the progenitor USA1100 MRSA was acquired, given the patient's multiple health care exposures, it is entirely possible that this strain was acquired in a health care setting. Our understanding of VRSA development suggests that polymicrobial infections with appropriate progenitor strains such as VRE and MRSA, which are typically health care associated, is an important prerequisite for the creation of VRSA, although additional biological barriers to VRSA formation likely exist. The many health care exposures of the patient described here clearly classify this as a health care-associated community onset case, but the most recent emergence of vancomycin resistance in a USA1100 strain suggests that strains typically thought of as health care associated are not the only ones that can acquire vanA.
